FDA: Deaths likely not linked to Viagra
May 22, 1998
Web posted at: 7:16 p.m. EDT (2316 GMT)
WASHINGTON (CNN) -- Six men taking the new impotence drug
Viagra have died, but the Food and Drug Administration says
there is no reason to believe that the deaths are linked to
the drug.
The FDA routinely requires the makers of all newly approved
drugs to file reports of any deaths among users. Pfizer Inc.,
which makes Viagra, reported the six deaths among more than a
million men who have taken the drug.
About 85 percent of the men taking Viagra are between the
ages of 50 and 70 and many suffer from serious medical
problems that are the underlying cause of their impotence.
"We are going to look into these reports as we do all adverse
reports," said FDA spokeswoman Lorrie McHugh. "We continue to
believe that the drug is safe and effective for its
indications and the patient population."
In clinical trials of Viagra, which involved only a few
thousand men, eight deaths were reported. None of those was
attributed to the use of the drug.
"Pfizer maintains that this is an effective and safe medicine
when used appropriately in men who have diagnosed erectile
dysfunction," said company spokeswoman Mariann Caprino. "Men
with erectile dysfunction tend to be older and frequently
suffer from serious underlying medical conditions, ranging
from diabetes to hypertension to cardiovascular disease."
However, in the wake of the reports, the FDA has asked Pfizer
to reiterate safety information to Viagra patients in order
to make sure the drug is being used properly.
The company advises that Viagra only be taken by men who have
erectile dysfunction diagnosed by a doctor after a medical
exam. It also notes that sexual activity among older patients
with known heart disease can be risky, which their doctors
should take into consideration.
The FDA has warned since approving the drug in March that it
is dangerous to take Viagra together with nitroglycerin or
related heart drugs. Such a warning appears on the drug's
label.
Reuters contributed to this report.